# FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

> **NCT02371031** · PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 11 (actual)

## Conditions studied

- Glioma
- Malignant Glioma

## Interventions

- **DRUG:** 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine
- **DEVICE:** PET/MRI
- **PROCEDURE:** Surgical resection (standard of care)

## Key facts

- **NCT ID:** NCT02371031
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Funding source for study ended.
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371031, "FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02371031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*